M/25/044 – SK Capital/Lisi Medical

Transaction details

The proposed acquisition by Remmele Acquisition and Girard Acquisition SAS which are controlled by Precision Holdings, LP, which is indirectly majority owned and solely controlled by funds that are controlled by affiliates of SK Capital Partners L.P. of sole control of Lisi Medical Remmele LLC, Lisi Medical SAS and their subsidiaries has been notified to the Competition and Consumer Protection Commission.

Notification date Decision date
Monday July 28, 2025
Parties Involved Business activities
SK Capital

SK Capital Partners is a US-based private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. It was founded in 2007 and is based in New York, USA. SK Capital Partners is active globally, through its portfolio companies, with a specific focus on North America, the EEA, the Middle East and Australia.

Lisi Medical

The Lisi Medical group comprises 4 entities, of which 3 are incorporated in France and one in the United States of America. The Lisi Medical group is active as a contract manufacturing organisation in the MedTech field, specialising in the industrial manufacturing of implants and instruments for minimally invasive, orthopaedic, spinal and trauma surgery. The Lisi Medical group provides its products to original equipment manufacturers of medical and surgical devices who sell the finished products under their branding to end customers.

Economic sector Media merger
Healthcare No
Submissions from third parties due by:
Phase 1 Phase 2
Monday, August 11, 2025
Current status: Active
Simplified Merger Notification
Authorised Officer Assigned Contact Details
Éadaoin Burns

eadaoinburns@ccpc.ie

Iseult O'Kelly

iseultokelly@ccpc.ie

Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Haven’t found what you’re looking for?